Literature DB >> 35089560

Soluble Recombinant Protein Production in Pseudoalteromonas haloplanktis TAC125: The Case Study of the Full-Length Human CDKL5 Protein.

Marzia Calvanese1, Andrea Colarusso1, Concetta Lauro1, Ermenegilda Parrilli1, Maria Luisa Tutino2.   

Abstract

The Antarctic bacterium Pseudoalteromonas haloplanktis TAC125 is an unconventional protein production host displaying a notable proficiency in the soluble production of difficult proteins, especially of human origin. Furthermore, the accumulation of recombinant products in insoluble aggregates has never been observed in this bacterium, indicating that its cellular physicochemical conditions and/or folding processes are rather different from those observed in mesophilic bacteria. The ability of this cell factory was challenged by producing a human protein, the cyclin-dependent kinase-like 5 (hCDKL5) in the bacterium cytoplasm at 0 °C. Human CDKL5 is a serine/threonine protein kinase characterized by the absence of a defined structure for the last two/third of its sequence, one of the largest intrinsically disordered regions so far observed in a human protein. This large unstructured domain makes difficult its production in most of the conventional hosts since the recombinant product accumulates as insoluble aggregates and/or is heavily proteolyzed. As the full-length hCDKL5 production is of great interest both for basic science and as protein drug for an enzyme replacement therapy, its production in the Antarctic bacterium was tested by combining the use of a regulated psychrophilic gene expression system with the use of a defined growth medium optimized for the host growth at subzero temperature. This is the first report of soluble and full-length recombinant production of hCDKL5 protein in a bacterium.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  GG medium; Human CDKL5_5; Intrinsically disordered Proteins; Pseudoalteromonas haloplanktis TAC125; Psychrophilic gene expression system pMAV

Mesh:

Substances:

Year:  2022        PMID: 35089560     DOI: 10.1007/978-1-0716-1859-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

2.  Intrinsic disorder in spondins and some of their interacting partners.

Authors:  Oluwole Alowolodu; Gbemisola Johnson; Lamis Alashwal; Iqbal Addou; Irina V Zhdanova; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-12-15

3.  Straightforward and rapid method for detection of cyclin-dependent kinase-like 5 activity.

Authors:  Syouichi Katayama; Tetsuya Inazu
Journal:  Anal Biochem       Date:  2018-11-14       Impact factor: 3.365

Review 4.  Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics.

Authors:  José Luis Corchero; Brigitte Gasser; David Resina; Wesley Smith; Ermenegilda Parrilli; Felícitas Vázquez; Ibane Abasolo; Maria Giuliani; Jussi Jäntti; Pau Ferrer; Markku Saloheimo; Diethard Mattanovich; Simó Schwartz; Maria Luisa Tutino; Antonio Villaverde
Journal:  Biotechnol Adv       Date:  2012-09-15       Impact factor: 14.227

5.  A novel synthetic medium and expression system for subzero growth and recombinant protein production in Pseudoalteromonas haloplanktis TAC125.

Authors:  F Sannino; M Giuliani; U Salvatore; G A Apuzzo; D de Pascale; R Fani; M Fondi; G Marino; M L Tutino; E Parrilli
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-27       Impact factor: 4.813

6.  Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis.

Authors:  Ileana Vigentini; Annamaria Merico; Maria Luisa Tutino; Concetta Compagno; Gennaro Marino
Journal:  J Biotechnol       Date:  2006-06-12       Impact factor: 3.307

7.  Coping with cold: the genome of the versatile marine Antarctica bacterium Pseudoalteromonas haloplanktis TAC125.

Authors:  Claudine Médigue; Evelyne Krin; Géraldine Pascal; Valérie Barbe; Andreas Bernsel; Philippe N Bertin; Frankie Cheung; Stéphane Cruveiller; Salvino D'Amico; Angela Duilio; Gang Fang; Georges Feller; Christine Ho; Sophie Mangenot; Gennaro Marino; Johan Nilsson; Ermenegilda Parrilli; Eduardo P C Rocha; Zoé Rouy; Agnieszka Sekowska; Maria Luisa Tutino; David Vallenet; Gunnar von Heijne; Antoine Danchin
Journal:  Genome Res       Date:  2005-09-16       Impact factor: 9.043

8.  Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A.

Authors:  Ugutz Unzueta; Felicitas Vázquez; Giulia Accardi; Rosa Mendoza; Verónica Toledo-Rubio; Maria Giuliani; Filomena Sannino; Ermenegilda Parrilli; Ibane Abasolo; Simo Schwartz; Maria L Tutino; Antonio Villaverde; José L Corchero; Neus Ferrer-Miralles
Journal:  Appl Microbiol Biotechnol       Date:  2015-01-24       Impact factor: 4.813

9.  Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1.

Authors:  Isamu Kameshita; Mari Sekiguchi; Daisuke Hamasaki; Yasunori Sugiyama; Naoya Hatano; Isao Suetake; Shoji Tajima; Noriyuki Sueyoshi
Journal:  Biochem Biophys Res Commun       Date:  2008-10-31       Impact factor: 3.575

10.  CDKL5 variants: Improving our understanding of a rare neurologic disorder.

Authors:  Ralph D Hector; Vera M Kalscheuer; Friederike Hennig; Helen Leonard; Jenny Downs; Angus Clarke; Tim A Benke; Judith Armstrong; Mercedes Pineda; Mark E S Bailey; Stuart R Cobb
Journal:  Neurol Genet       Date:  2017-12-15
View more
  1 in total

1.  Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.

Authors:  Andrea Colarusso; Concetta Lauro; Marzia Calvanese; Ermenegilda Parrilli; Maria Luisa Tutino
Journal:  Microb Cell Fact       Date:  2022-10-14       Impact factor: 6.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.